| 1. |
- Andersson, Dag R., et al.
(författare)
-
A molecular beam scattering apparatus for surface chemiluminescence studies. Preliminary results for emission of excited K atoms.
- 1989
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- A molecular beam scattering apparatus has been constructed for the study of surface chemiluminescence, i.e. the emission of light during a molecule-surface reaction. The apparatus consists of a beam forming stage designed for molecular and atomic chlorine, and a scattering chamber. The scattering chamber houses the sample, an alkali evaporation source, and a rotatable flange which holds the detectors; (i) the imaging optics of the photon detector, (ii) a mass spectrometer detector and (iii) a charged particle collector. The performance of the apparatus is demonstrated for a beam of chlorine molecules impinging on continuously evaporated or freshly evaporated potassium films. Intensity versus chlorine exposure and angular intensity distributions are presented for the K(4p ->4s) atomic line emission of the K+Cl$_2$ surface chemiluminescence spectrum.
|
|
| 2. |
- Ingemarsson, Ingemar, et al.
(författare)
-
Effects of isradipine, a new calcium antagonist, on postpartum uterine activity
- 1989
-
Ingår i: Acta Obstetricia et Gynecologica Scandinavica. - : Wiley. - 1600-0412 .- 0001-6349. ; 68:8, s. 725-730
-
Tidskriftsartikel (refereegranskat)abstract
- The effects of a new calcium antagonist, isradipine (PN 200-110) on postpartum uterine activity and the maternal cardiovascular system were investigated. Uterine activity was recorded by a microtip transducer catheter inserted transcervically within 45 min of normal vaginal delivery. 0.5 mg of isradipine was given as a bolus injection during 5 min to 7 women with spontaneous uterine activity and 1 mg was given during a 15-min period to another 8 women with oxytocin-stimulated uterine activity. Matched controls with similar pre-injection activity (+/- 5%) but not given the drug were selected for comparison. The effects of the drug in 3 women (given 1 mg of isradipine) were compared with those in matched controls and in women given 0.25 mg of terbutalin i.v. as a bolus injection. Isradipine had a marked inhibitory effect on both spontaneous and oxytocin-stimulated uterine activity. The inhibitory effect of 1 mg of isradipine seemed comparable to that of 0.25 mg of terbutalin. The inhibition occurred within 1-2 min after the injection and was sustained throughout the study period (2 h). A transient reduction of the systolic (mean maximum decrease 10-15%) and diastolic blood pressure (mean maximum decrease 15-20%) was seen, particularly during the injection period. Hypotension (systolic blood pressure less than 80 mmHg) was not recorded. A moderate increase in pulse rate (mean maximum increase 22-27%) was seen in all cases. The results show that isradipine given as a bolus injection can inhibit early postpartum uterine activity, with minimal side effects.
|
|
